Recent Quotes (30 days)

You have no recent quotes
chg | %

Aphria Inc  

(Public, CVE:APH)   Watch this stock  
Find more results for APH
6.55
-0.20 (-2.96%)
Delayed:   3:03PM EST
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 6.50 - 6.70
52 week 1.14 - 7.79
Open 6.70
Vol / Avg. 3.53M/1.31M
Mkt cap 743.37M
P/E 164.61
Div/yield     -
EPS 0.04
Shares 112.31M
Beta     -
Inst. own     -
Jan 16, 2017
Q2 2017 Aphria Inc Earnings Release (Estimated)
  

Key stats and ratios

Q4 (Nov '16) 2016
Net profit margin 18.09% 4.72%
Operating margin 9.31% -12.93%
EBITD margin - -1.59%
Return on average assets 3.43% 1.57%
Return on average equity 3.79% 1.65%
CDP Score - -

Address

269 Erie St S, PO Box 20009
LEAMINGTON, ON N8H 3C4
Canada

Website links

Description

Aphria Inc., formerly Black Sparrow Capital Corp., is a Canada-based company, which is engaged in producing and selling medical marijuana through retail sales and wholesale channels. The Company's retail sales are primarily sold through the Company's online store, as well as telephone orders. Its wholesale shipments are sold to other Medical Purposes Regulations (MMPR) Licensed Producers. It offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. Its cannabis oil products will include Champlain, Rideau and Capilano. Its cannabis oil products will be available in approximately 60 milliliter bottles. Its subsidiaries include Pure Natures Wellness Inc., which is engaged in producing and selling medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in providing support services to veterans and first responders.